This session of Cooley’s AI Talks will cover ways to navigate the US, European Union, and UK regulatory and legislative risks of AI, including strategies for engaging with policymaking bodies and analyzing the business...more
11/5/2024
/ Algorithms ,
Artificial Intelligence ,
Bias ,
Bots ,
Continuing Legal Education ,
Deep Fake ,
Disclosure Requirements ,
EU ,
Government Agencies ,
Legislative Agendas ,
Machine Learning ,
New Legislation ,
New Regulations ,
Proposed Legislation ,
Proposed Regulation ,
Regulatory Agenda ,
Regulatory Oversight ,
Regulatory Requirements ,
Right of Publicity ,
Technology Sector ,
Transparency ,
UK ,
Webinars
On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) released the first set of negotiated prices for the Medicare Drug Price Negotiation Program for 2026. Authorized under the Inflation Reduction Act of...more
On May 22, 2024, the Consumer Financial Protection Bureau (CFPB) issued an interpretive rule stating that providers of “buy now, pay later” (BNPL) products that issue “digital user accounts” to access credit products to...more
The National Telecommunications and Information Administration (NTIA) announced a request for comment regarding the potential risks and benefits of dual-use foundation models with weights that are widely available. NTIA also...more
On Friday, January 5, 2024, the US Food and Drug Administration (FDA) authorized the Section 804 Importation Program (SIP) proposal of Florida’s Agency for Health Care Administration (FAHCA). The SIP is a pathway that allows...more
This session will cover ways to navigate the US, European Union and UK regulatory and legislative risks of AI, including strategies for engaging with policymaking bodies and analyzing the business impacts of legislation and...more
12/7/2023
/ Artificial Intelligence ,
Bots ,
Continuing Legal Education ,
Deep Fake ,
Disclosure Requirements ,
EU ,
Government Agencies ,
Innovation ,
Libel ,
Proposed Legislation ,
Proposed Regulation ,
Regulatory Requirements ,
UK ,
Unfair or Deceptive Trade Practices ,
Webinars
The extent to which the federal government will regulate artificial intelligence (AI) is a hot topic in Washington, DC. In September 2023, the US Senate held a closed-door forum, followed by another forum in October, with AI...more
On October 30, 2023, the Biden administration issued a long-awaited executive order (EO) on artificial intelligence (AI). The EO expands on previous AI initiatives, such as the Blueprint for an AI Bill of Rights, and lays out...more
On April 11, 2023, the US Department of Education (ED) announced that it will modify and further delay the implementation of its controversial guidance on third-party servicer (TPS) issues.
This latest update comes in...more
Key Takeaways -
On August 11, 2022, the Federal Trade Commission announced an advance notice of proposed rulemaking (ANPR) to initiate a process that would allow it to develop and enforce rules on what the FTC has termed...more
On December 9, 2021, one of the nation’s top healthcare prosecutors made clear that clinical trial fraud will be a major enforcement priority of President Joe Biden’s Department of Justice. Speaking at the Food and Drug Law...more
The FTC announced that it had issued Notices of Penalty Offense to for-profit colleges and was cracking down on unfair and deceptive conduct in the education marketplace.
During a closed press conference last week, the...more
For proprietary institutions subject to the 90/10 rule, President Joe Biden’s signing of the American Rescue Plan Act of 2021 on March 11 reflects a major change in this revenue test that provides for-profit institutions and...more
Borrowers and lenders have eagerly anticipated additional details and guidance on the Federal Reserve's rollout of the $600 billion Main Street Lending Program, as there has been scant information regarding the specific...more
Since the Federal Reserve's announcement on April 9 of the rollout of its Main Street Lending Program1, lenders and borrowers have eagerly anticipated additional guidance on key aspects of the program. On April 30, 2020, the...more
As has been widely anticipated, the Treasury and the Federal Reserve Board released the details of their previously announced Main Street Lending Program to promote liquidity in the lending market for small to medium sized...more
The CARES Act, a $2 trillion relief package signed into law on Friday, authorizes the US Treasury Department to provide up to an aggregate of $500 billion for loans, loan guarantees and other investments for eligible...more
A key feature of the CARES Act $2 trillion relief package is the creation of the Paycheck Protection Program (PPP), which authorizes $349 billion for businesses to obtain loans of up to $10 million per applicant to be used on...more
As has been well publicized, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) is a $2 trillion economic relief package enacted to help individuals and businesses in the United States weather the severe...more
3/30/2020
/ Business Interruption ,
CARES Act ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
Economic Injury Disaster Loans ,
Federal Loans ,
Financial Stimulus ,
NAICS ,
Paycheck Protection Program (PPP) ,
Relief Measures ,
SBA ,
SBA Lending Programs ,
Small Business ,
Tax Exempt Entities ,
Tax Relief
The President has signed a $2 trillion relief package, the "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act). The CARES Act is intended to provide "emergency assistance and health care response for individuals,...more
3/29/2020
/ Affiliated-Business Arrangements ,
Business Interruption ,
CARES Act ,
Coronavirus/COVID-19 ,
Economic Injury Disaster Loans ,
Employee Retention ,
Executive Compensation ,
Federal Loans ,
Financial Stimulus ,
Paycheck Protection Program (PPP) ,
Payroll Taxes ,
Relief Measures ,
SBA ,
SBA Lending Programs ,
Small Business ,
Tax Relief
The estimated $2+ trillion stimulus bill – the Coronavirus Aid, Relief and Economic Security Act (the CARES Act) – is meant to address the economic crisis caused by the coronavirus pandemic. The act will pump hundreds of...more
In 2019, Congress and the Administration set out to make strides to effectuate policies to curb the rising costs of prescription drugs. These efforts while significant in number, were few in completion. Congress, while...more
Yesterday, the Department of Health and Human Services (HHS) announced two “pathways” for drug importation. This plan is the latest step in the Administration’s push to lower prescription drug prices and one the President has...more
Earlier this morning, the White House announced that they were scrapping a proposed rule (the rebate rule) that, among other items, would have [would eliminate the current safe harbor protection under the Anti-Kickback...more
Legislation that addresses the cost of prescription drugs is inching closer to moving out of Congress. On Yesterday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the bipartisan Lower...more